Thousands of NY COVID patients are being treated with anti-malarial drug

https://nypost.com/2020/04/05/ny-coronavirus-patients-being-treated-with-anti-malarial-drug/

I n terms of the NYU clinical trial regarding prevention, researchers are enrolling 2,000 adult volunteers at six sites.

They are recruiting people who lack any COVID-19 symptoms but have been in close contact with others who have a confirmed or pending diagnosis.

On a random basis, the trial participants will receive either hydroxychloroquine or a placebo pill — vitamin C — every day for two weeks.